ReVision has secured funding from Plug and Play! We’re excited to join one of the world’s leading innovation platforms, connecting us with a global network of investors, mentors, and industry leaders. This support marks another important step in accelerating our mission to develop the first truly effective visual prosthesis for blind people worldwide.
The expertise that we have developed in extreme miniaturization of medical devices is also finding its way to use cases beyond visual prostheses: in that regard, we are proud to announce that we have signed a long-term supply contract with Elmedix, to deliver a critical component to be used in their therapy.Elmedix is a clinical-stage medtech company that is developing a revolutionary heat-based therapy for metastasized cancers. We wish them all the best in their coming second round of clinical tests, and are happy to be part of their journey!
We're thrilled to announce that we've entered into our first research partnership with a world-leading medtech company, Cochlear Inc.
Cochlear's implants have helped over 750.000 profoundly deaf people reconnect to the world of sound. As a forward-thinking company, they are constantly striving to further improve their technology in order to even better help patients. We are truly honored to be allowed to contribute to this mission!
Great news - ReVision Implant joins project partners KU Leuven, Miguel Hernandez University (Spain) and the HUN-REN TTK Research Centre for Natural Sciences (Hungary) in a pan-European collaboration financed by the EU's Innovation Council. Together, we are aiming for a world-first implantation and test of flexible, high resolution microelectrode array in the primary visual cortex of a blind volunteer, a major milestone on our path to creating the first well working visual prosthesis for blind people worldwide.
Great news, imec.istart has invested in ReVision! We are thrilled to have the support of Europe’s #1 university-linked accelerator as we continue developing our groundbreaking visual prosthesis technology. With their expertise and network, we are confident this collaboration will accelerate our mission to bring sight restoration closer to reality for blind people worldwide.
Would you like to learn more about our work? If you'd happen to be in Helsinki on November 21, feel free to visit us at the Slush start-up conference. We'll be joining the delegation headed by Flanders Investment and Trade there, and have a booth at the festival on November 21.
Breaking news: ReVision has been accepted to the European Medicine Agency's orphan medical device pilot program! This program will enable a more easy market access for devices with life-altering implications for relatively small patient groups (<12.000 per year in the EU). We happen to just fit in.
After several years of hard work and numerous animal tests, we are confident enough in our approach to start concrete preparations for first-in-human testing of our implant. The process will have several steps: we will first do short-term testing of the electrode arrays and then move gradually towards a full long-term test of the entire system. Dr. Lara Merken is joining our team in the new role of clinical trial manager to coordinate these efforts. Thanks again to VLAIO for supporting these efforts!
We are happy to announce that the second generation of our neurostimulator chip has been taped out by our project partner KU Leuven. It is a heavily upscaled version of an earlier design that was successfully tested last year. The chip will now be manufactured by TSMC and will be ready for integration in our system early in 2025. It will be used in the first fully implantable version of our system, which will allow to address over 2000 microelectrodes in the visual cortex. Picture is for illustration only, the actual design is still confidential!
We are proud to announce we've entered in a collaboration with prof. Wim Dehaene of the MICAS research group of KU Leuven, Belgium. MICAS is a key player in research on integrated circuits, and will play an important role in further advancing the electronics required for our implants. The R&D project is supported by VLAIO in the framework of the 'StimChip' project.
We have presented our technology at the European Brain Council's Brain Innovation Days, and were awarded the 'Innovation Showcase Award'. Thanks to all that made the progress we've recently made possible!
.jpeg)
Interested in a live conversation with the ReVision team? You will have a chance to meet us in person at Slush'D, the largest gathering of start-ups and investors in the world. We will be present both at the local exhibition in Leuven as well as at the international edition in Helsinki.
After a year of hard work and radio silence, we will present the progress we have made at The Eye and The Chip, a conference sponsored by the Henry Ford Foundation that brings together researchers and companies in vision restauration worldwide. Thanks to dr. Hessburg for inviting us for a platform presentation!
Our 'HyperStim' EIC project was featured in this month's Horizon Magazine. Earlier this summer, we were also mentioned in the newspapers De Morgen and HLN.
Our very own Laurens Goyvaerts made a remarkable impression as keynote spead on this year's AFT Medtech Convention, leading to our booth being the most visited of the conference. Congratulations, Laurens!
We are proud to announce that, together with out partners at KULeuven (Belgium), UPF (Barcelona) and TTK (Hungary) we have been awarded a prestigious 'Pathfinder' grant from the European Innovation Council. This 2.2 million € grant will allow us to thoroughly study the advanced neurostimulation strategies needed to enhance the resolution of visual prostheses 20X compared to the state of the art. Our sincere thanks go to the jury for supporting our vision that will allow to drastically improve treatment options for blind people worldwide!
ReVision and Atlas Neuroengineering, a company that builds and sells neural probes for preclinical research applicatons, submitted a joint grant proposal to the Flemish government to ask for support in further developing flexible neural electrode technology. Recently, we received news about the posititive evaluation of this proposal. We thank the jury for their trust and support. This grant will be instrumental in helping us to evaluate the long-term performance of our implants in several use cases.
We have received an excellent official search report about our first patent from the European Patent Office. This means the chance that our first patent will be awarded without much hassle is extremely high. Our sincere thanks go to the fine patent lawyers at IPLodge!
ReVision and KU Leuven are proud to announce that our colleague, Maarten Schelles, received a Baekeland PhD grant from the Flemish government. It will allow Maarten to work for 4 years on a research project that directly contributes to the further development of visual prostheses. We are more than grateful to have him in our team!
